🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Treatment for Opioid Use Disorder

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site📍 Indianapolis Proniras Corporation · Tests: Tezampanel, Placebo Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons NCT06999811NA1 site📍 Charleston Medical University of South Carolina · Tests: Empowering Pregnant Women and People Receiving medications for opioid use disorder (EMPWR), Medication monitoring (cont… Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment NCT07071766NA1 site📍 Little Rock University of Arkansas · Tests: Proud of Baby and Me Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses NCT07631598NA8 sites📍 Los Angeles📍 Washington D.C.📍 Baton Rouge Montefiore Medical Center · Tests: Standard of Care Referral, Low Threshold Buprenorphine Disclosure Intervention for People in Treatment for Opioid Use Disorder NCT06458985NA1 site📍 Wilmington University of Delaware · Tests: Disclosing Recovery: A Decision Aid and Toolkit Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment NCT07342504NA1 site📍 Notre Dame University of Notre Dame · Tests: Brief opioid-informed alcohol treatment Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery NCT07115030NA3 sites📍 Bridgeport📍 Enfield📍 West Haven Yale University · Tests: PCT+2HOPE The Youth Opioid Recovery Support (YORS) Intervention NCT04173416NA1 site📍 Baltimore Potomac Health Foundations · Tests: Youth Opioid Recovery Support (YORS) A Clinical Trial of Telehealth Treatment for Opioid Use Disorders NCT07362082NA1 site📍 New Haven Yale University · Tests: RecoveryPad platform Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families NCT06685003NA1 site📍 New York We The Village, Inc. · Tests: Digital Tutorial overview, Digital Tutorial plus training Materials, Digital Tutorial plus training Materials plus feed… Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment NCT06323837Phase 21 site📍 Spokane Washington State University · Tests: Mirtazapine, Placebo PRoducing Outcome Measures for OTP Quality Improvement NCT07214389NA1 site📍 Research Triangle Park RTI International · Tests: Quality Measures (Audit and Feedback), Quality Improvement (QI) Toolkit, External QI Facilitation Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD NCT06774248NA1 site📍 Baltimore Potomac Health Foundations · Tests: Youth Opioid Recovery Support (YORS) Opioid Adherence and Support Through Innovative Texting Strategies NCT07350148NA1 site📍 Albuquerque University of New Mexico · Tests: Mindfulness text messages Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase NCT07787039NA1 site📍 Philadelphia Friends Research Institute, Inc. · Tests: STORC Semaglutide for Helping Opioid Recovery NCT06639464Phase 21 site📍 Boston Brigham and Women's Hospital · Tests: Semaglutide, Placebo Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment NCT07024498NA4 sites📍 El Centro📍 Irvine📍 Placerville University of California, Davis · Tests: care coordination implementation strategies Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD NCT06157840NA1 site📍 Charleston Medical University of South Carolina · Tests: mHealth application and sleep health education, Simplified mHealth application and sleep health education Focused Ultrasound for the Complex Patient NCT06453109NA1 site📍 Washington D.C. Washington D.C. Veterans Affairs Medical Center · Tests: low intensity focused ultrasound (LIFU) Adaptive Decision Support for Addiction Treatment Master NCT06799117NA3 sites📍 Guilford📍 New Haven📍 New Haven Yale University · Tests: EMBED CDS, Nurse prompt to complete COWS, Provider Prompt, Patient facing materials, Optimized EMBED Ketamine for Opioid Use Disorder NCT06943859Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Treatment with Ketamine, Treatment with Very Low Dose Ketamine Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment NCT06032559Phase 32 sites📍 New Brunswick📍 Salt Lake City Rutgers, The State University of New Jersey · Tests: MORE, SMP, TAU Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations NCT05702021NA9 sites📍 Chicago📍 Chicago📍 Chicago Northwestern University · Tests: Science to Service Laboratory Opioids, Low Nicotine Cigarettes, and Chronic Pain NCT06747871NA1 site📍 Durham Duke University · Tests: Very Low Nicotine Cigarettes (VLNC), Normal Nicotine Cigarettes (NNC) Personalized Addiction Treatment enHancement NCT07778394NA1 site📍 Providence Rhode Island Hospital · Tests: Vira Platform, Treatment-As-Usual Optimizing Pregnancy and Treatment Interventions for Moms 3.0 NCT07586917NA1 site📍 Salt Lake City University of Utah · Tests: Patient Navigation Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder NCT05011266Phase 2, Phase 32 sites📍 Rockville📍 New York New York State Psychiatric Institute · Tests: Buprenorphine/naloxone, Placebo Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy NCT05985850Phase 21 site📍 Vancouver BC Centre on Substance Use · Tests: Aurora 1:1 Drops (Indica), Placebo Building Retention and Initiation Through Delivery of Peer-Guided Evidence-Based Practices NCT07541417NA1 site📍 Greenville Prisma Health-Upstate · Tests: Certified Peer Support Specialist Intervention Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial NCT07439549Phase 42 sites📍 Vancouver📍 Vancouver Pouya Azar · Tests: Naloxone Hydrochloride 0.4 MG/ML, Buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablet (2…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy